Search Results - "Motta, Irene"

Refine Results
  1. 1

    Reactivation of Developmentally Silenced Globin Genes by Forced Chromatin Looping by Deng, Wulan, Rupon, Jeremy W., Krivega, Ivan, Breda, Laura, Motta, Irene, Jahn, Kristen S., Reik, Andreas, Gregory, Philip D., Rivella, Stefano, Dean, Ann, Blobel, Gerd A.

    Published in Cell (14-08-2014)
    “…Distal enhancers commonly contact target promoters via chromatin looping. In erythroid cells, the locus control region (LCR) contacts β-type globin genes in a…”
    Get full text
    Journal Article
  2. 2

    Rise of the planet of rare anemias: An update on emerging treatment strategies by Fattizzo, Bruno, Motta, Irene

    Published in Frontiers in medicine (09-01-2023)
    “…Therapeutic options for rare congenital (hemoglobinopathies, membrane and enzyme defects, congenital dyserythropoietic anemia) and acquired anemias [warm…”
    Get full text
    Journal Article
  3. 3

    Drug Design and Development for Rare Hematologic Diseases by Fattizzo, Bruno, Capecchi, Marco, Motta, Irene

    Published in Pharmaceuticals (Basel, Switzerland) (01-10-2023)
    “…The last decade has seen an exponential increase in therapeutic options for rare hematologic diseases [...]…”
    Get full text
    Journal Article
  4. 4

    Pharmacological Induction of Fetal Hemoglobin in β-Thalassemia and Sickle Cell Disease: An Updated Perspective by Bou-Fakhredin, Rayan, De Franceschi, Lucia, Motta, Irene, Cappellini, Maria Domenica, Taher, Ali T.

    Published in Pharmaceuticals (Basel, Switzerland) (16-06-2022)
    “…A significant amount of attention has recently been devoted to the mechanisms involved in hemoglobin (Hb) switching, as it has previously been established that…”
    Get full text
    Journal Article
  5. 5

    Elevated liver iron concentration is a marker of increased morbidity in patients with β thalassemia intermedia by MUSALLAM, Khaled M, CAPPELLINI, Maria Domenica, WOOD, John C, MOTTA, Irene, GRAZIADEI, Giovanna, TAMIM, Hani, TAHER, Ali T

    Published in Haematologica (Roma) (01-11-2011)
    “…Patients with β thalassemia intermedia can have substantial iron overload, irrespectively of their transfusion status, secondary to increased intestinal iron…”
    Get full text
    Journal Article
  6. 6

    CURING HEMOGLOBINOPATHIES: CHALLENGES AND ADVANCES OF CONVENTIONAL AND NEW GENE THERAPY APPROACHES by Motta, Irene, Ghiaccio, Valentina, Cosentino, Andrea, Breda, Laura

    “…Inherited hemoglobin disorders, including beta-thalassemia (BT) and sickle-cell disease (SCD) are the most common monogenic diseases worldwide, with a global…”
    Get full text
    Journal Article
  7. 7

    Innovative Treatments for Rare Anemias by Cappellini, Maria Domenica, Marcon, Alessia, Fattizzo, Bruno, Motta, Irene

    Published in HemaSphere (01-06-2021)
    “…Rare anemias (RA) are mostly hereditary disorders with low prevalence and a broad spectrum of clinical severity, affecting different stages of erythropoiesis…”
    Get full text
    Journal Article
  8. 8

    Interpreting Iron Homeostasis in Congenital and Acquired Disorders by Scaramellini, Natalia, Fischer, Dania, Agarvas, Anand R, Motta, Irene, Muckenthaler, Martina U, Mertens, Christina

    Published in Pharmaceuticals (Basel, Switzerland) (21-02-2023)
    “…Mammalian cells require iron to satisfy their metabolic needs and to accomplish specialized functions, such as hematopoiesis, mitochondrial biogenesis, energy…”
    Get full text
    Journal Article
  9. 9

    Alternative Pathway Involvement in Protoporphyria Patients Related to Sun Exposure by Granata, Francesca, Duca, Lorena, Brancaleoni, Valentina, Fustinoni, Silvia, De Luca, Giacomo, Motta, Irene, Graziadei, Giovanna, Di Pierro, Elena

    Published in Frontiers in immunology (16-02-2021)
    “…The homeostasis of tissues in a chronic disease is an essential function of the alternative pathway (AP) of the complement system (CS). However, if not…”
    Get full text
    Journal Article
  10. 10

    Clinical Complications and Their Management by Marcon, Alessia, MD, Motta, Irene, MD, Taher, Ali T., MD, PhD, FRCP, Cappellini, Maria Domenica, MD

    “…The hallmarks of thalassemias are ineffective erythropoiesis and peripheral hemolysis leading to a cascade of events responsible for several clinical…”
    Get full text
    Journal Article
  11. 11

    Migalastat Treatment in a Kidney-Transplanted Patient with Fabry Disease and N215S Mutation: The First Case Report by Di Stefano, Valeria, Mancarella, Marta, Camporeale, Antonia, Regalia, Anna, Ferraresi, Marta, Pisaniello, Marco, Cassinerio, Elena, Pieruzzi, Federico, Motta, Irene

    Published in Pharmaceuticals (Basel, Switzerland) (14-12-2021)
    “…Fabry disease is a rare X-linked lysosomal storage disorder caused by mutations in the GLA gene, leading to deficient α-galactosidase A activity and,…”
    Get full text
    Journal Article
  12. 12

    ACQUIRED REFRACTORY IRON DEFICIENCY by Migone De Amicis, Margherita, Rimondi, Alessandro, Elli, Luca, Motta, Irene

    “…Anemia is a global health problem affecting one-third of the world population, and half of the cases are due to iron deficiency (ID). Iron de?ciency anemia…”
    Get full text
    Journal Article
  13. 13

    Heme Biosynthetic Gene Expression Analysis With dPCR in Erythropoietic Protoporphyria Patients by Granata, Francesca, Brancaleoni, Valentina, Barman-Aksözen, Jasmin, Scopetti, Margherita, De Luca, Giacomo, Fustinoni, Silvia, Motta, Irene, Di Pierro, Elena, Graziadei, Giovanna

    Published in Frontiers in physiology (18-07-2022)
    “…Background: The heme biosynthesis (HB) involves eight subsequent enzymatic steps. Erythropoietic protoporphyria (EPP) is caused by loss-of-function mutations…”
    Get full text
    Journal Article
  14. 14

    Differential Redox State and Iron Regulation in Chronic Obstructive Pulmonary Disease, Acute Respiratory Distress Syndrome and Coronavirus Disease 2019 by Duca, Lorena, Ottolenghi, Sara, Coppola, Silvia, Rinaldo, Rocco, Dei Cas, Michele, Rubino, Federico Maria, Paroni, Rita, Samaja, Michele, Chiumello, Davide Alberto, Motta, Irene

    Published in Antioxidants (14-09-2021)
    “…In patients affected by Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Coronavirus Disease 2019 (COVID-19),…”
    Get full text
    Journal Article
  15. 15

    ACTIVIN RECEPTOR LIGAND FOR THR TREATMENT OF BETA-THALASSEMIA: a SERENDIPITOUS DISCOVERY by Motta, Irene, Brancaleoni, Valentina, Nava, Isabella, Delbini, Paola, Duca, Lorena

    “…b-thalassemia is a hereditary disorder caused by defective production of b-globin chains of hemoglobin (Hb) that leads to an increased a/b globins ratio with…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Redox Balance in β-Thalassemia and Sickle Cell Disease: A Love and Hate Relationship by Bou-Fakhredin, Rayan, De Franceschi, Lucia, Motta, Irene, Eid, Assaad A, Taher, Ali T, Cappellini, Maria Domenica

    Published in Antioxidants (13-05-2022)
    “…β-thalassemia and sickle cell disease (SCD) are inherited hemoglobinopathies that result in both quantitative and qualitative variations in the β-globin chain…”
    Get full text
    Journal Article
  18. 18

    α-Lipoic Acid Improves Hepatic Metabolic Dysfunctions in Acute Intermittent Porphyria: A Proof-of-Concept Study by Longo, Miriam, Paolini, Erika, Meroni, Marica, Duca, Lorena, Motta, Irene, Fracanzani, Anna Ludovica, Di Pierro, Elena, Dongiovanni, Paola

    Published in Diagnostics (Basel) (06-09-2021)
    “…Acute intermittent porphyria (AIP) is caused by the haploinsufficiency of porphobilinogen deaminase (PBGD) enzymatic activity. Acute attacks occur in response…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Iron deficiency from the standpoint of cardiac rehabilitation: novel therapeutic opportunities by Malfatto, Gabriella, Frisinghelli, Anna, Ambrosetti, Marco, La Rovere, Maria Teresa, Motta, Irene, Passaretti, Bruno, Pavesi, Marco, Tramarin, Roberto, Dasseni, Niccolò, Faggiano, Pompilio

    Published in Monaldi archives for chest disease (20-09-2019)
    “…Anemia is one of the most frequent comorbidities found in patients with coronary artery disease and chronic heart failure (CHF) who are being followed in…”
    Get full text
    Journal Article